Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1487948Generated: October 26, 2026

5-(Piperidin-4-YL)-1H-indazole → 4-(1-(4-Cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)-3-fluoroazetidin-3-yl)benzonitrile

https://huagongshe.com/reaction/1487948

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(Piperidin-4-YL)-1H-indazoleHCID 49760859—
Reactant4-(3-Fluoroazetidin-3-yl)benzonitrile hydrochlorideHCID 90021334—
Reactant4-Cyclobutyl-2-methyl-5-(methylcarbamoyl)benzoic acidHCID 90022051—
ReactantHCID 178433965HCID 178433965—
Product4-(1-(4-Cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)-3-fluoroazetidin-3-yl)benzonitrileHCID 178433964—

Reaction Steps

The title compound was prepared using standard chemical manipulations and procedures similar to those used for the preparation of compound 62, except 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoic acid (compound 78.4) was used in place of 4-cyclobutyl-2-methyl-5-(methylcarbamoyl)benzoic acid (compound 62.3) and 4-(3-fluoroazetidin-3-yl)benzonitrile hydrochloride (compound 43.4) was used in place of 5-(piperidin-4-yl)-1H-indazole (compound 62.5). m/z (ES+) 430 (M+H)+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09428502B2
Source datasetuspto-grants-2016_08
ORD IDord-bdfae158759d4788bd4efca37f8abb66
Source noteuspto-grants-2016_08